Medical Director at the Hennessy Institute for Cancer Prevention and Applied Molecular Medicine, Hackensack Meridian John Theurer Cancer Center, New Jersey, and Associate Professor at Hackensack Meridian School of Medicine, USA.
United States
Prof. Elias I. Obeid is a board-certified medical oncologist and hematologist who specializes in breast cancer, Ovarian cancer, and prostate cancer. He is the Medical Director at the Hennessy Institute for Cancer Prevention and Applied Molecular Medicine, Hackensack Meridian John Theurer Cancer Center, New Jersey, and Associate Professor at Hackensack Meridian School of Medicine, USA. His research interests include breast cancer risk assessment, prevention, and treatment.
Prof. Elias I. Obeid is a medical oncologist and hematologist who specializes in breast cancer. He is currently the Medical Director at the Hennessy Institute for Cancer Prevention and Applied Molecular Medicine, Hackensack Meridian John Theurer Cancer Center, New Jersey, and Associate Professor at Hackensack Meridian School of Medicine, USA.
Prof. Obeid received his medical degree from the American University of Beirut School of Medicine, Lebanon, in 2000. He completed his residency in internal medicine at Yale New Haven Medical Center, USA, in 2004, and his fellowship in medical oncology and hematology at the University of Chicago Medical Center, USA, in 2012. He also completed an advanced research fellowship in medical oncology at the University of Chicago Medical Center in 2013.
Prof. Obeid is a board-certified medical oncologist and is licensed to practice medicine in Pennsylvania and New Jersey. He is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the American College of Physicians.
Prof. Obeid's research interests include breast cancer risk assessment, prevention, and treatment. He has published numerous articles in peer-reviewed journals and has presented his research at national and international conferences. He is also the recipient of several awards for his research, including the Young Investigator Award from the National Comprehensive Cancer Network (NCCN) Foundation in 2016.
Prof. Obeid is committed to providing his patients with the highest quality cancer care. He is passionate about his work and is dedicated to helping his patients overcome their cancer.
Hackensack Meridian School of Medicine, USA.
The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine, Hackensack Meridian John Theurer Cancer Center, New Jersey, USA
Saint Joseph Health Cancer Center, Hackensack, New Jersey, USA
Fox Chase Cancer Center, Philadelphia, PA, USA
Fox Chase Cancer Center, Philadelphia, PA, USA
Fox Chase Cancer, Philadelphia, PA, USA
The University of Chicago, Chicago, IL, USA
Department of Medicine, Yale University, USA
Department of Medicine, Yale University, USA
Internal Medicine Residency Program, Hospital of Saint Raphael, New Haven, CT, USA
American Board of Internal Medicine
2013
American Association for Cancer Research
American Society of Clinical Oncology
American College of Physicians